Advancing digital health applications: priorities for innovation in real-world evidence generation

In 2019, Germany passed the Digital Healthcare Act, which, among other things, created a “Fast-Track” regulatory and reimbursement pathway for digital health applications in the German market. The pathway explicitly provides for flexibility in how researchers can present evidence for new digital pro...

Full description

Saved in:
Bibliographic Details
Main Authors: Stern, Ariel Dora (Author) , Brönneke, Jan (Author) , Debatin, Jörg F (Author) , Hagen, Julia (Author) , Matthies, Henrik (Author) , Patel, Smit (Author) , Clay, Ieuan (Author) , Eskofier, Bjoern (Author) , Herr, Annika (Author) , Hoeller, Kurt (Author) , Jaksa, Ashley (Author) , Kramer, Daniel B (Author) , Kyhlstedt, Mattias (Author) , Lofgren, Katherine T (Author) , Mahendraratnam, Nirosha (Author) , Muehlan, Holger (Author) , Reif, Simon (Author) , Riedemann, Lars (Author) , Goldsack, Jennifer C (Author)
Format: Article (Journal)
Language:English
Published: 23 February 2022
In: The lancet. Digital health
Year: 2022, Volume: 4, Issue: 3, Pages: e200-e206
ISSN:2589-7500
DOI:10.1016/S2589-7500(21)00292-2
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/S2589-7500(21)00292-2
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S2589750021002922
Get full text
Author Notes:Ariel D Stern, Jan Brönneke, Jörg F Debatin, Julia Hagen, Henrik Matthies, Smit Patel, Ieuan Clay, Bjoern Eskofier, Annika Herr, Kurt Hoeller, Ashley Jaksa, Daniel B Kramer, Mattias Kyhlstedt, Katherine T Lofgren, Nirosha Mahendraratnam, Holger Muehlan, Simon Reif, Lars Riedemann, Jennifer C Goldsack
Description
Summary:In 2019, Germany passed the Digital Healthcare Act, which, among other things, created a “Fast-Track” regulatory and reimbursement pathway for digital health applications in the German market. The pathway explicitly provides for flexibility in how researchers can present evidence for new digital products, including the use of real-world data and real-world evidence. Against this backdrop, the Digital Medicine Society and the Health Innovation Hub of the German Federal Ministry of Health convened a set of roundtable discussions to bring together international experts in evidence generation for digital medicine products. This Viewpoint highlights findings from these discussions with the aims of (1) accelerating and stimulating innovative approaches to digital medical product evaluation, and (2) promoting international harmonisation of best evidentiary practices. Advancing these topics and fostering international agreement on evaluation approaches will be vital to the safe, effective, and evidence-based deployment and acceptance of digital health applications globally.
Item Description:Gesehen am 08.04.2022
Physical Description:Online Resource
ISSN:2589-7500
DOI:10.1016/S2589-7500(21)00292-2